• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸二甲双胍和格列吡嗪口腔崩解片的研制与评价。

Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.

机构信息

Department of Pharmaceutical Technology, Hacettepe University, Ankara, Turkey.

Department of Pharmaceutical Technology, Ataturk University, Erzurum, Turkey.

出版信息

Pharm Dev Technol. 2020 Oct;25(8):999-1009. doi: 10.1080/10837450.2020.1772290. Epub 2020 Jun 11.

DOI:10.1080/10837450.2020.1772290
PMID:32431206
Abstract

Diabetes is characterized by chronic hyperglycemia. Although metformin hydrochloride (MHCl)- and glyburide (GLB)-containing conventional tablets are available in the market and used to treat diabetes, orally disintegrating tablets (ODTs) containing the combination of these drugs are not commercially available. Therefore, the aim of this study was to prepare ODTs containing MHCl and GLB by direct-compression (DC-ODTs) and freeze-drying (FD-ODTs) methods. Physical properties of the powder mixture of DC-ODT formulation were determined (Angle of repose: 37.18 ± 1.27°; compressibility index: 20.31 ± 1.06%; Hausner ratio: 1.25 ± 0.03). Its moisture content was 0.3 ± 0.09%. The hardness values and the disintegration times for DC-ODTs and FD-ODTs were 221.60 ± 40.82 and 66.54 ± 2.68 N, and 80 and 30 s, respectively. Friability values were 0.24% for DC-ODTs and 0.38% for FD-ODTs. In uniformity-of-mass for single-dose-preparations test, the average weight was 684.38 ± 1.97 mg for DC-ODTs and 342.93 ± 2.4 mg for FD-ODTs, with less than 5% deviation for all 20 tablets. Water-absorption ratio for DC-ODTs was 1.30 ± 0.05. More than 90% of MHCl and GLB were dissolved within 5 min in both DC-ODTs and FD-ODTs. Although Caco-2 permeability of MHCl was influenced by the ODTs, GLB permeability was not. These results indicated that MHCl- and GLB-containing ODTs may be used as promising formulations for the treatment of diabetes.

摘要

糖尿病的特征是慢性高血糖。虽然市场上有含有盐酸二甲双胍(MHCl)和格列本脲(GLB)的常规片剂,并且用于治疗糖尿病,但含有这些药物的口服分散片(ODT)尚未商业化。因此,本研究旨在通过直接压片(DC-ODT)和冷冻干燥(FD-ODT)方法制备含有 MHCl 和 GLB 的 ODT。测定了 DC-ODT 配方粉末混合物的物理性质(休止角:37.18±1.27°;可压缩性指数:20.31±1.06%;Hausner 比:1.25±0.03)。其水分含量为 0.3±0.09%。DC-ODT 和 FD-ODT 的硬度值和崩解时间分别为 221.60±40.82 和 66.54±2.68 N 和 80 和 30 s。DC-ODT 的脆碎度值为 0.24%,FD-ODT 的脆碎度值为 0.38%。在单剂量制剂测试的均匀度-质量测试中,DC-ODT 的平均重量为 684.38±1.97 mg,FD-ODT 的平均重量为 342.93±2.4 mg,所有 20 片的偏差均小于 5%。DC-ODT 的吸水率为 1.30±0.05。在 DC-ODT 和 FD-ODT 中,MHCl 和 GLB 均在 5 分钟内溶解超过 90%。虽然 MHCl 的 Caco-2 渗透性受到 ODT 的影响,但 GLB 的渗透性不受影响。这些结果表明,含有 MHCl 和 GLB 的 ODT 可能是治疗糖尿病的有前途的制剂。

相似文献

1
Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.盐酸二甲双胍和格列吡嗪口腔崩解片的研制与评价。
Pharm Dev Technol. 2020 Oct;25(8):999-1009. doi: 10.1080/10837450.2020.1772290. Epub 2020 Jun 11.
2
Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.通过直接压片法制备并评价含速尿的口腔崩解片。
Pharmazie. 2017 Jul 3;72(7):389-394. doi: 10.1691/ph.2017.6149.
3
Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.采用共处理赋形剂的巴氯芬-美洛昔康口崩片(ODTs)的配方和评价以及使用六西格玛方法改善 ODTs 性能。
Drug Des Devel Ther. 2021 Oct 16;15:4383-4402. doi: 10.2147/DDDT.S327193. eCollection 2021.
4
Formulation studies for mirtazapine orally disintegrating tablets.米氮平口腔崩解片的处方研究
Drug Dev Ind Pharm. 2016;42(6):1008-17. doi: 10.3109/03639045.2015.1104345. Epub 2015 Nov 4.
5
Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.含盐酸二甲双胍掩味固体脂质微丸的口崩片:工艺参数对片剂性质的影响。
Eur J Pharm Biopharm. 2018 Jan;122:137-145. doi: 10.1016/j.ejpb.2017.10.018. Epub 2017 Oct 26.
6
Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.Prosolv和Prosolv:甘露醇200直接压片填充剂对阿托伐他汀口腔崩解片物理机械性能的影响。
Pharm Dev Technol. 2015 Jun;20(4):394-400. doi: 10.3109/10837450.2013.871031. Epub 2014 Jan 8.
7
Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets.开发一种新型直接可压缩共处理赋形剂及其在米氮平口腔崩解片配方中的应用。
Drug Dev Ind Pharm. 2024 Jan;50(1):36-44. doi: 10.1080/03639045.2023.2294095. Epub 2024 Jan 30.
8
Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.右美沙芬氢溴酸盐口服分散片的研制与优化:处方和工艺变量的影响。
Pharm Dev Technol. 2013 Mar-Apr;18(2):454-63. doi: 10.3109/10837450.2012.710237. Epub 2012 Aug 13.
9
Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.含掩味萘普生钠颗粒和盐酸那拉曲坦的新型口腔崩解片的处方、制备及评价
J Pharm Sci. 2014 Apr;103(4):1233-45. doi: 10.1002/jps.23896. Epub 2014 Feb 15.
10
Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and and characterization.含卡马西平和左乙拉西坦的口崩片:制剂及特性研究。
Drug Dev Ind Pharm. 2021 Jul;47(7):1153-1165. doi: 10.1080/03639045.2021.1988094. Epub 2021 Oct 11.

引用本文的文献

1
Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review.口腔黏膜给药制剂的生物利用度提高及制剂技术:综述
Pharmaceutics. 2025 Jan 22;17(2):148. doi: 10.3390/pharmaceutics17020148.
2
Optimization of Glyburide-loaded Nanosuspensions Ball Milling and Homogenization Techniques: A Central Composite Design Approach for Enhanced Solubility.格列本脲纳米混悬液的优化 球磨法与均质化技术:一种提高溶解度的中心复合设计方法
Curr Pharm Des. 2025;31(5):377-390. doi: 10.2174/0113816128321501240828054050.
3
An Industrial Procedure for Pharmacodynamic Improvement of Metformin HCl via Granulation with Its Paracellular Pathway Enhancer Using Factorial Experimental Design.
采用因子实验设计,通过颗粒化并用其细胞旁途径增强剂来提高盐酸二甲双胍药效学的工业方法。
Drug Des Devel Ther. 2021 Nov 2;15:4469-4487. doi: 10.2147/DDDT.S328262. eCollection 2021.